Table 1.
Testing of each patient's sample nine months after transfusion
| Initial tests | Confirmatory tests* |
|---|---|
| Hepatitis B virus | |
| Hepatitis B surface antigen (EIA) | Hepatitis B surface antigen (EIA, neutralising) |
| Anti-hepatitis B core (EIA) | Anti-hepatitis B core (RIA*) |
| Anti-hepatitis B surface (RIA*) | |
| Hepatitis C virus | |
| Anti-hepatitis C virus (EIA) | Anti-hepatitis C virus (EIA) |
| Anti-hepatitis C virus RIBA-3 | |
| HIV | |
| Anti-HIV 1 and 2 (EIA) | Anti-HIV (EIA, GPA, western blot) |
| Human T cell leukaemia/lymphoma virus | |
| Anti-HTLV (GPA) | Anti-HTLV (EIA, GPA, western blot) |
*
Performed at reference laboratory (department of virology, Royal Free and University College Medical School) according to standard protocols in use at time.